This randomized, double-blind Phase 2 trial will evaluate Saroglitazar Magnesium ... was issued.During the year 2021, Zydus Discovery DMCC (ZDD), a subsidiary of the Company completed Phase ...
Qure (QURE) announced that the Independent Data Monitoring Committee for EPISOD1, uniQure’s Phase I/II clinical trial of AMT-162, an ...
About 61% of patients with stage I or II dMMR colon cancer achieved a pathologic complete response after a single cycle of neoadjuvant pembrolizumab, new data revealed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback